BB-401

· Benitec Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BB-401, covering 2020-04-15 to 2020-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2]